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Abstract
Background: Measurements of hormonal concentrations by immunoassays using fluorescent
tracer substance (Eu3+) are susceptible to the action of chemical agents that may cause alterations
in its original structure. Our goal was to verify the effect of two types of anticoagulants in the
hormone assays performed by fluorometric (FIA) or immunofluorometric (IFMA) methods.
Methods: Blood samples were obtained from 30 outpatients and were drawn in EDTA, sodium
citrate, and serum separation Vacutainer®Blood Collection Tubes. Samples were analyzed in
automatized equipment AutoDelfia™ (Perkin Elmer Brazil, Wallac, Finland) for the following
hormones: Luteinizing hormone (LH), Follicle stimulating homone (FSH), prolactin (PRL), growth
hormone (GH), Sex hormone binding globulin (SHBG), thyroid stimulating hormone (TSH), insulin,
C peptide, total T3, total T4, free T4, estradiol, progesterone, testosterone, and cortisol. Statistical
analysis was carried out by Kruskal-Wallis method and Dunn's test.
Results: No significant differences were seen between samples for LH, FSH, PRL and free T4.
Results from GH, TSH, insulin, C peptide, SHBG, total T3, total T4, estradiol, testosterone,
cortisol, and progesterone were significant different between serum and EDTA-treated samples
groups. Differences were also identified between serum and sodium citrate-treated samples in the
analysis for TSH, insulin, total T3, estradiol, testosterone and progesterone.
Conclusions: We conclude that the hormonal analysis carried through by FIA or IFMA are
susceptible to the effects of anticoagulants in the biological material collected that vary depending
on the type of assay.
Background
Measurements of hormone concentrations in physiologi-
cal fluids are used as biochemical indicators of endocrino-
logical status and as therapy monitors [1]. Hormones are
measured by immunoassays using different types of trac-
ers, such as radioactive, enzymatic, chemiluminescent or
fluorescent substances. The latter method has many ad-
vantages: it provides good resolution, is very accurate, has
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long-lasting reagents, can be automated and is easy to per-
form [2]. However, it uses a fluorescent tracer substance
(Eu3+) coupled to the antigen or antibody as a chelat [3],
being susceptible to the action of chemical agents that
may cause alterations in its original structure.
Currently, serum is the matrix of choice for hormone anal-
ysis through fluoro- or immunofluorometric assays [4].
EDTA is a powerful chelating agent and will bind to me-
tallic ions that are a constituent of labels or act as cofactors
for enzymatic activities [5].
In our routine analyses, we observed some elevated values
whose results were not confirmed after dilution. The aim
of this study was to verify the analytical variation among
samples treated with EDTA and sodium citrate compared
with serum samples, in hormone assays performed by
fluorometric (FIA) and immunofluorometric (IFMA)
methods.
Materials and methods
Three different types of Vacutainer tubes were purchased
from Becton Dickinson (Franklin Lanes, NJ, USA): (1) a
serum separation tube which contained an inert barrier
(gel) for cleaner separation of serum from coagulum dur-
ing centrifugation (Vacutainer®Blood Collection Tubes,
Hemograd SST), (2) a whole blood tube with liquid EDTA
(Vacutainer®Blood Collection Tubes, K3 EDTA, 15%), (3)
a whole blood tube with 0.129 mol/L buffered sodium ci-
trate (Vacutainer®Blood Collection Tubes, 9NC, 3,8% so-
dium citrate). Blood samples were collected from 30
outpatients (11 men and 19 women; 19–61 years of age)
after a minimum of 10 h fasting into EDTA, sodium cit-
rate, and serum separation Vacutainer tubes. The serum or
plasma was separated from the blood cells immediately
after the blood was drawn by centrifugation at 2000 g for
5 min. Each sample was then analyzed in the automated
machine AutoDelfia™ (Perkin Elmer Brazil, Wallac, Turku,
Finland) for the following hormones, according to the
manufacturer's instructions: LH spec, FSH, Prolactin
(PRL), GH, SHBG, TSH Ultra, Insulin (INS) and C-Peptide
(C-PEP) measured by IFMA method; Total T3 (TT3), Total
T4 (TT4), free T4 (FT4), E2, Progesterone (PROG), Testo-
sterone (TESTO), and Cortisol (F) measured by FIA meth-
od.
Statistical analysis was carried out by Kruskal-Wallis
method followed by Dunn's test. The results from EDTA
and citrate plasma were each compared to those measured
in serum, and if there was a significant (p < 0,05) differ-
ence this was considered a significant effect of anticoagu-
lant. All statistical analysis and plotting were performed
using SigmaStat 2.0 software (Jandel Scientific, Chicago).
Results
Tables 1 and 2 shows median and range of values ob-
tained from hormonal measurements in serum, EDTA-
treated and citrate-treated samples by IFMA and FIA assays
respectively. The range of hormone concentrations varied
among sample types (tables 1 and 2). No statistically sig-
nificant differences were seen between EDTA-treated sam-
ples, sodium citrate-treated samples and serum samples in
IFMA assays for LH spec (p = 0.822), FSH (p= 0.653), PRL
(p = 0.277), and FIA assay for FT4 (p = 0.208), based on
Kruskal-Wallis one way analysis of variance. Results from
IFMA assays (Table 1) for SHBG, GH, TSH, INS, CPEP and
FIA assays (Table 2) for TT3, TT4, E2, TESTO, F and PROG
presented a statistically significant difference between se-
rum and EDTA-treated sample groups. Compared to se-
rum samples, EDTA-plasma samples rendered lower
results for IFMA assays and higher values for FIA assays
(Fig 1 and Fig 2). We also identified statistically significant
differences between serum and sodium citrate-treated
samples in the IFMA assays (Table 1) for TSH, INS, and
FIA assays (Table 2) for TT3, TT4, E2, TESTO and PROG.
We noted that F results of citrate-treated samples showed
values slightly elevated when compared to serum samples
results, but difference was not statistically significant (Ta-
ble 2). Citrate-treated samples also rendered lower results
for IFMA assays and higher values for FIA assays when
compared to serum samples results (Table 1 and 2)
Discussion
Blood collection for hormone analysis is an important
factor in the quality of the final result, and if incorrectly
carried out could produce problems such as physicians'
interpretative errors, additional costs caused by patients'
recall for extra collections and/or analysis replication for
result confirmation.
EDTA can react with the labeled reagent and produce a
chelat with the Eu3+ ion being eluted from the well. In
FIA this effect is shown as an increased value, while in
IFMA assays lower results are obtained. The manufactur-
er's instructions briefly describe which type of sample can
be analyzed, warning users of the possibility of false re-
sults. However, in a routine laboratory that receives mate-
rial in separated form, it is difficult to discriminate
between serum and plasma.
In our study we observed a great influence of EDTA plas-
ma on the competitive FIA assays with an inversely pro-
portional relationship between the emitted signal and the
concentration of the hormone. The EDTA and the citrate
present in the sample extract the Eu3+ ions from the label
through their chelating action, thus lowering the fluores-
cent signal and increasing final results. This fact explains
the great rise of the values obtained in plasma assays of
E2, TESTO, PROG, F, TT3 and TT4. In the non-competitiveBMC Clinical Pathology 2002, 2 http://www.biomedcentral.com/1472-6890/2/2
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IFMA assays, the relation between the signal and the con-
centration is directly proportional and the effect of antico-
agulants is a reduction of the fluorescent signal with the
consequent generation of falsely lower results. Four hor-
mones did not present statistically significant differences
(LH spec, FSH, PRL, and FT4), mostly analyzed by IFMA
assays. Probably two incubations in the LH assays spec,
FSH, and PRL explain the lesser influence of anticoagu-
lants on these analyses. FT4 by FIA method, in which the
effect was not observed, is the only assay that requires
three incubations, and it is tempting to conclude that
there is a lack of interference due to the shorter time of
contact between reagents and/or to the dilution of the an-
ticoagulant in the sample. In the FIA assays the effect is ev-
idenced by elevated results that require many replications
of the analyses, with sample dilutions. On the other hand,
in IFMA assays this influence is not easily noticed, raising
a question from the clinical standpoint.
Recently, Evans et al. examined the effect of three of the
most commonly used anticoagulants and serum, as well
as the effect with each of these collection methods of stor-
ing samples frozen, at 4°C or at 30°C for 24 and 120
hours, on 22 hormones measurements using radioimmu-
Table 1: Results of the hormonal measurements in serum, EDTA-treated and citrated-treated plasma (median and range) by IFMA as-
says. (p < 0.05)
IFMA
SERUM EDTA CITRATE
median range median range median range
LH spec IU/L 5.9 0.07–54 5.6 0.06 -51 5.13 0.06 -49
FSH IU/L 6.8 0.02–119 6.55 0.01–108 5.83 0.01–94
PRL ng/mL 5.53 1.6–171 5.2 1.4–152 4.6 1.2–137
GH ng/mL 0.18 0.02–2.4 0.03*a 0.01–4.7 0.11a 0.01–8.2
INS µIU/mL 6.95 2.3–27 < 4.8*# <4.8 4.8* 0.2–11
CPEP ng/mL 1.78 0.7–8.3 0.39*a 0.2–1.7 1.13a 0.4–4.9
SHBG nmol/L 47.1 14–367 28.6* 8.3–315 37.5 11–336
TSH µIU/mL 1.46 0.03–100 0.03*a 0.02–0.28 0.45*a 0.01–53
range refers to minimum and maximum values * statistical significant difference between EDTA or citrate plasma results and serum (p < 0.05) a sta-
tistical significant difference between EDTA and citrate plasma results (p < 0.05) # Insulin in EDTA samples was undetectable.
Table 2: Results of the hormonal measurements in serum, EDTA-treated and citrated-treated plasma (median and range) by FIA as-
says. (p < 0.05)
FIA
SERUM EDTA CITRATE
median range median range median range
E2 pg/mL 25.6 6.9–8280 2480*a 949–10700 63.6*a 41–8580
TESTO ng/dL 31.7 9.1–1060 687*a 68–2800 202*a 56–2460
PROG ng/mL 0.3 0.2–38 38*a 23–38 0.7*a 0.4–38
F µg/dL 11.7 6.1–37 145.6*a 58–154 13.1a 7.4–39
T3 ng/dL 122 42–201 >650*a 204 – >650 209*a 94 – >650
T4 µg/dL 9.2 3.2 – 17 23.3*a 11 – 23.3 10.2*a 4.1 – 23.3
FT4 ng/dL 0.91 0.43 – 1.62 0.91 0.43 – 1.96 0.99 1.46 – 2.19
range refers to minimum and maximum values * statistical significant difference between EDTA or citrate plasma results and serum (p < 0.05) a sta-
tistical significant difference between EDTA and citrate plasma results (p < 0.05)BMC Clinical Pathology 2002, 2 http://www.biomedcentral.com/1472-6890/2/2
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noassay, immunoradiometric assay or enzyme immu-
noassay. They found that when the different collection
methods were compared to collection in EDTA, a signifi-
cant effect was shown for several hormones. This suggests
that samples sent to a laboratory should be collected into
the appropriate anticoagulant for that laboratory's meth-
ods [6].
We conclude that the hormonal analyses carried out by
FIA or IFMA are susceptible to the effect of anticoagulants
in plasma and that the effect varies depending on the type
of assay. The analyses must always be carried out in se-
rum, free of metal-complexing anticoagulant, thus giving
a more trustworthy result. Updating of the professionals
involved with the collection of blood samples must be
carried out, so that they are able to prevent interferences.
Technicians should be aware of the possibility of interfer-
ences. This would both lower costs and provide better
quality test results.
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Figure 1
Effect of EDTA and citrate on the T assay using fluorometric
method. Mean hormone concentrations (± SD) are repre-
sented by the box; medians are plotted as a line inside the
box; error bars represents 10th and 90th percentiles; dots
outside box are values that falls outside the 10th and 90th
percentiles; significant (*p < 0.05) differences between serum
and EDTA or serum and citrate are indicated by an asterisk.
Figure 2
Effect of EDTA and citrate on the TSH assay using immun-
ofluorometric method. Mean hormone concentrations (±
SD) are represented by the box; medians are plotted as a line
inside the box; error bars represents 10th and 90th percen-
tiles; dots outside box are values that falls outside the 10th
and 90th percentiles; significant (*p < 0.05) differences
between serum and EDTA or serum and citrate are indicated
by an asterisk.
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